Cargando…
Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models
BACKGROUND: Metastatic disease lacks effective treatments and remains the primary cause of mortality from epithelial cancers, especially breast cancer. The metastatic cascade involves cancer cell migration and invasion and modulation of the tumor microenvironment (TME). A viable anti-metastasis stra...
Autores principales: | Torres-Sanchez, Anamaris, Rivera-Robles, Michael, Castillo-Pichardo, Linette, Martínez-Ferrer, Magaly, Dorta-Estremera, Stephanie M., Dharmawardhane, Suranganie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313121/ https://www.ncbi.nlm.nih.gov/pubmed/37397366 http://dx.doi.org/10.3389/fonc.2023.1152458 |
Ejemplares similares
-
Targeting Rac and Cdc42 GEFs in Metastatic Cancer
por: Maldonado, Maria del Mar, et al.
Publicado: (2020) -
Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade
por: Rivera Rivera, Amilcar, et al.
Publicado: (2016) -
Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice
por: Castillo-Pichardo, Linette, et al.
Publicado: (2013) -
The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model
por: Castillo-Pichardo, Linette, et al.
Publicado: (2014) -
Characterization of Novel Derivatives of MBQ-167, an Inhibitor of the GTP-binding Proteins Rac/Cdc42
por: Medina, Julia I., et al.
Publicado: (2022)